These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4288365)

  • 1. The effect of heparin on aldosterone secretion and metabolism in primary aldosteronism.
    Ford HC; Bailey RE
    Steroids; 1966 Jan; 7(1):30-40. PubMed ID: 4288365
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of adrenal function in man by heparin or heparinoid Ro 1-8307.
    Kloppenborg PW; Casparie AF; Benraad TJ; Majoor CL
    Acta Med Scand; 1975; 197(1-2):99-108. PubMed ID: 47702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
    Kaufmann W
    Arzneimittelforschung; 1969 May; 19(5):802-3. PubMed ID: 5819794
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory determinations of aldosterone and their clinical significance.
    Horton R
    Am J Clin Pathol; 1970 Sep; 54(3):297-302. PubMed ID: 4319206
    [No Abstract]   [Full Text] [Related]  

  • 5. The regulation of aldosterone secretion in primary aldosteronism.
    Cain JP; Tuck ML; Williams GH; Dluhy RG; Rosenoff SH
    Am J Med; 1972 Nov; 53(5):627-37. PubMed ID: 4342887
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights into the medical management of primary aldosteronism.
    Hsueh WA
    Hypertension; 1986 Jan; 8(1):76-82. PubMed ID: 3510974
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of aldosterone in peripheral blood and urine--analysis of the method and evaluation of estimated values in normal subjects and aldosteronism].
    Tsai ZH
    Nihon Naika Gakkai Zasshi; 1969 Oct; 58(10):1070-82. PubMed ID: 5389748
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
    Wisgerhof M; Brown RD
    J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
    Nielsen I; Jacobsen J
    Acta Med Scand; 1970 May; 187(5):401-9. PubMed ID: 5526958
    [No Abstract]   [Full Text] [Related]  

  • 12. A decreased metabolic clearance rate of aldosterone in benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J
    J Clin Invest; 1971 Oct; 50(10):2184-90. PubMed ID: 5116208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological influences on aldosterone secretion.
    Garcia-Robles R; Ruilope LM
    J Steroid Biochem; 1987; 27(4-6):947-51. PubMed ID: 2961944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.
    Balikian HM; Brodie AH; Dale SL; Melby JC; Tait JF
    J Clin Endocrinol Metab; 1968 Nov; 28(11):1630-40. PubMed ID: 5697040
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
    Horton R
    Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
    [No Abstract]   [Full Text] [Related]  

  • 16. Deoxycorticosterone secretion in chronic experimental heart failure and during infusion of angiotensin II.
    Davis JO; Howards SS; Johnston CI; Wright FS
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):164-8. PubMed ID: 4296243
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone.
    Postel-Vinay MC; Alberti GM; Ricour C; Limal JM; Rappaport R; Royer P
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1038-44. PubMed ID: 4372243
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone in clinical medicine.
    Wolff HP
    Acta Endocrinol (Copenh); 1968; ():Suppl 124:65+. PubMed ID: 4295469
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma desoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, cortisol and 11-deoxycortisol.
    Oddie CJ; Coghlan JP; Scoggins BA
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1039-54. PubMed ID: 4336456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.